Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
RITANSERIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RITANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
145TFV465S
Molecule Type:
Small molecule
Molecular Formula:
C27H25F2N3OS
Molecular Weight:
477.58
AlogP:
5.48
PSA:
37.61
HBD:
0.0
HBA:
#RotB:
5.0
Source:
INCB-047986
(2)
Small molecule
Tyrosine-protein kinase JAK1 inhibitor
Unknown
Investigational
Unknown
INCB-047986
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TETRAHYDROPALMATINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TETRAHYDROPALMATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
3X69CO5I79
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO4
Molecular Weight:
355.43
AlogP:
3.38
PSA:
40.16
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FIALURIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FIALURIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
53T7IN77LC
Molecule Type:
Small molecule
Molecular Formula:
C9H10FIN2O5
Molecular Weight:
372.09
AlogP:
-1.27
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
LAPACHONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LAPACHONE
×
Maximum Phase:
2
First Approval:
None
UNII:
6N4FA2QQ6A
Molecule Type:
Small molecule
Molecular Formula:
C15H14O3
Molecular Weight:
242.27
AlogP:
2.75
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
0.0
Source:
MIVAVOTINIB CITRATE
(2)
Small molecule
Tyrosine-protein kinase SYK inhibitor
Unknown
Investigational
Unknown
MIVAVOTINIB CITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
6ZJ8V3Q0H1
Molecule Type:
Small molecule
Molecular Formula:
C23H29FN6O8
Molecular Weight:
536.52
AlogP:
1.55
PSA:
97.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
ACETIC ACID C-11
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ACETIC ACID C-11
×
Maximum Phase:
2
First Approval:
None
UNII:
2A9OM7IPNW
Molecule Type:
Small molecule
Molecular Formula:
C2H4O2
Molecular Weight:
59.05
AlogP:
0.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
VIPIVOTIDE TETRAXETAN GALLIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VIPIVOTIDE TETRAXETAN GALLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C49H68GaN9O16
Molecular Weight:
1108.85
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CEPHARANTHINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CEPHARANTHINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAF312
(2)
Small molecule
Vanilloid receptor inhibitor
Unknown
Investigational
Unknown
SAF312
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUINACRINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
QUINACRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
H0C805XYDE
Molecule Type:
Small molecule
Molecular Formula:
C23H30ClN3O
Molecular Weight:
399.97
AlogP:
5.97
PSA:
37.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ALUMINUM PHOSPHATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALUMINUM PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
F92V3S521O
Molecule Type:
Small molecule
Molecular Formula:
AlO4P
Molecular Weight:
121.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-863233
(2)
Small molecule
Cell division cycle 7-related protein kinase inhibitor
Unknown
Investigational
Unknown
BMS-863233
×
Maximum Phase:
2
First Approval:
None
UNII:
8QK62S7492
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClN3O2
Molecular Weight:
289.72
AlogP:
2.75
PSA:
70.92
HBD:
2.0
HBA:
#RotB:
1.0
Source:
EMAVUSERTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EMAVUSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATX08-001
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma modulator
Unknown
Investigational
Unknown
ATX08-001
×
Maximum Phase:
2
First Approval:
None
UNII:
V5Q32BZX79
Molecule Type:
Small molecule
Molecular Formula:
C21H23Cl2N3O3S
Molecular Weight:
468.41
AlogP:
4.95
PSA:
81.06
HBD:
1.0
HBA:
#RotB:
8.0
Source:
QUERCETIN-3'-O-PHOSPHATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
QUERCETIN-3'-O-PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
E2I4458LJN
Molecule Type:
Small molecule
Molecular Formula:
C15H11O10P
Molecular Weight:
382.22
AlogP:
1.75
PSA:
177.89
HBD:
6.0
HBA:
#RotB:
3.0
Source:
ANABASEINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ANABASEINE
×
Maximum Phase:
2
First Approval:
None
UNII:
DYE103K23I
Molecule Type:
Small molecule
Molecular Formula:
C10H12N2
Molecular Weight:
160.22
AlogP:
2.05
PSA:
25.25
HBD:
0.0
HBA:
#RotB:
1.0
Source:
N-ACETYLGLUCOSAMINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
N-ACETYLGLUCOSAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
8P59336F68
Molecule Type:
Small molecule
Molecular Formula:
C8H15NO6
Molecular Weight:
221.21
AlogP:
-3.08
PSA:
119.25
HBD:
5.0
HBA:
#RotB:
2.0
Source:
NEOANDROGRAPHOLIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NEOANDROGRAPHOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
XBY0Z806J2
Molecule Type:
Small molecule
Molecular Formula:
C26H40O8
Molecular Weight:
480.6
AlogP:
1.85
PSA:
125.68
HBD:
4.0
HBA:
#RotB:
7.0
Source:
DAPORINAD
(2)
Small molecule
Nicotinamide phosphoribosyltransferase inhibitor
Unknown
Investigational
Unknown
DAPORINAD
×
Maximum Phase:
2
First Approval:
None
UNII:
V71TF6V9M7
Molecule Type:
Small molecule
Molecular Formula:
C24H29N3O2
Molecular Weight:
391.52
AlogP:
3.93
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PREDNYLIDENE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PREDNYLIDENE
×
Maximum Phase:
2
First Approval:
None
UNII:
IF8PQP966U
Molecule Type:
Small molecule
Molecular Formula:
C22H28O5
Molecular Weight:
372.46
AlogP:
1.72
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TAS-106
(2)
Small molecule
DNA-directed RNA polymerase I subunit RPA1 inhibitor
Unknown
Investigational
Unknown
TAS-106
×
Maximum Phase:
2
First Approval:
None
UNII:
Y3O05I09ZK
Molecule Type:
Small molecule
Molecular Formula:
C11H13N3O5
Molecular Weight:
267.24
AlogP:
-2.56
PSA:
130.83
HBD:
4.0
HBA:
#RotB:
2.0
Source:
TIGULIXOSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TIGULIXOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
WZ0PYQ6VLU
Molecule Type:
Small molecule
Molecular Formula:
C16H14N4O2
Molecular Weight:
294.31
AlogP:
2.98
PSA:
83.84
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BX-471
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BX-471
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOLIMIDONE
(2)
Small molecule
Tyrosine-protein kinase Lyn positive allosteric modulator
Unknown
Investigational
Unknown
TOLIMIDONE
×
Maximum Phase:
2
First Approval:
None
UNII:
MU3JD8E9IS
Molecule Type:
Small molecule
Molecular Formula:
C11H10N2O2
Molecular Weight:
202.21
AlogP:
2.28
PSA:
55.24
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TAK-715
(2)
Small molecule
MAP kinase p38 alpha inhibitor
Unknown
Investigational
Unknown
TAK-715
×
Maximum Phase:
2
First Approval:
None
UNII:
WE92U03C5Z
Molecule Type:
Small molecule
Molecular Formula:
C24H21N3OS
Molecular Weight:
399.52
AlogP:
6.0
PSA:
54.88
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AMITHIOZONE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AMITHIOZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
MMG78X7SSR
Molecule Type:
Small molecule
Molecular Formula:
C10H12N4OS
Molecular Weight:
236.3
AlogP:
0.81
PSA:
79.51
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TOVINONTRINE
(2)
Small molecule
Phosphodiesterase 9A inhibitor
Unknown
Investigational
Unknown
TOVINONTRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
W248Y1AKOR
Molecule Type:
Small molecule
Molecular Formula:
C21H26N6O2
Molecular Weight:
394.48
AlogP:
1.94
PSA:
88.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
INDOLE-3-CARBINOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
INDOLE-3-CARBINOL
×
Maximum Phase:
2
First Approval:
None
UNII:
C11E72455F
Molecule Type:
Small molecule
Molecular Formula:
C9H9NO
Molecular Weight:
147.18
AlogP:
1.66
PSA:
36.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
BERSACAPAVIR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BERSACAPAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
2456KW2166
Molecule Type:
Small molecule
Molecular Formula:
C16H14F4N4O3S
Molecular Weight:
418.37
AlogP:
2.52
PSA:
103.99
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BRILACIDIN
(2)
Small molecule
Membrane disrupting agent
Unknown
Investigational
Unknown
BRILACIDIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I1679X069H
Molecule Type:
Small molecule
Molecular Formula:
C40H50F6N14O6
Molecular Weight:
936.92
AlogP:
3.68
PSA:
308.5
HBD:
12.0
HBA:
#RotB:
20.0
Source:
LOTAMILAST
(2)
Small molecule
Phosphodiesterase 4 inhibitor
Unknown
Investigational
Unknown
LOTAMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
TO043KKB9C
Molecule Type:
Small molecule
Molecular Formula:
C26H24N4O5
Molecular Weight:
472.5
AlogP:
4.39
PSA:
111.67
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AGANEPAG ISOPROPYL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AGANEPAG ISOPROPYL
×
Maximum Phase:
2
First Approval:
None
UNII:
R096XE6760
Molecule Type:
Small molecule
Molecular Formula:
C27H37NO4S
Molecular Weight:
471.66
AlogP:
6.45
PSA:
66.84
HBD:
1.0
HBA:
#RotB:
12.0
Source:
IFETROBAN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IFETROBAN
×
Maximum Phase:
2
First Approval:
None
UNII:
E833KT807K
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O5
Molecular Weight:
440.54
AlogP:
4.12
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
11.0
Source:
APLINDORE FUMARATE
(2)
Small molecule
Dopamine D2 receptor partial agonist
Unknown
Investigational
Unknown
APLINDORE FUMARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
P13TV5A758
Molecule Type:
Small molecule
Molecular Formula:
C22H22N2O7
Molecular Weight:
426.43
AlogP:
2.11
PSA:
59.59
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ST-101
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ST-101
×
Maximum Phase:
2
First Approval:
None
UNII:
7TTT61784C
Molecule Type:
Small molecule
Molecular Formula:
C15H12N2O
Molecular Weight:
236.27
AlogP:
1.85
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
0.0
Source:
1
2
…
130
131
132
133
134
135
136
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA